OCU-10-C-110

· Ocugenix Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OCU-10-C-110, covering 2025-03-21 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration [Phase 1]

See pricing